First‐in‐Human Pharmacokinetics and Safety Study of GSK3008356, a Selective DGAT1 Inhibitor, in Healthy Volunteers - Okour, Malek; Gress, Angela; Zhu, Xinyi; Rieman, David; Lickliter, Jason D.; Brigandi, Richard A. (Clinical pharmacology in drug development, 2019)
Keywords: Biosynthesis; Clinical trials; DGAT inhibitor; Drug therapy; Enzymes; GSK3008356; healthy volunteers; Inhibitor drugs; Pharmacokinetics; Pharmacology; safety; pharmacokinetics; DGAT inhibitor; GSK3008356; safety; healthy volunteers